COVID-19 MRNA VACCINE DEVELOPMENT PROGRAM: FIRST PARTICIPANTS IN THE U.S.

May 8, 2020
First participants dosed at NYU Grossman School of Medicine and University of Maryland School of Medicine. Pfizer and BioNTech ramping up manufacturing capabilities to further increase production capacity in 2020/2021